August 4, 2025
PETALING JAYA – Beginning August 1, the enforcement of the medicine price display rule under the Price Control and Anti-Profiteering Act 2011 will continue in stages through education, inspection and advocacy until Sept 30.
The Health Ministry in a statement on Sunday (Aug 3) said a letter of warning may be issued in the event of non-compliance, with compound notices to be issued starting Oct 1 and full enforcement on Jan 1, 2026.
The implementation of the medicine price display initiative in private healthcare facilities and community pharmacies began on May 1, 2025.
“The implementation of this initiative is a strategic collaboration between the Health Ministry and the Domestic Trade and Cost of Living Ministry.
“The educational enforcement approach was implemented for the first three months, which ended on July 31.
“During this period, 842 facilities consisting of medical clinics, dental clinics and private hospitals, as well as community pharmacies, were inspected, and the majority of them have implemented this initiative, with 57% of them complying with the drug price display requirements satisfactorily,” the ministry said.
Both ministries also took note of the report on the judicial review action filed in the High Court by seven organisations representing medical and dental practitioners and one private medical practitioner, regarding the validity of the order.
However, the Health Ministry said there has been no court order directing the suspension of the implementation or enforcement of the order.
Starting May 1, all private healthcare facilities and community pharmacies were required to display the prices of medicines.
The scope of price labelling encompasses all medicines for human use, including prescription and non-prescription medications, over-the-counter products, traditional medicines, health supplements and extemporaneously prepared products.